These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 19177421)

  • 1. Inverse-electron-demand Diels-Alder reaction as a highly efficient chemoselective ligation procedure: synthesis and function of a BioShuttle for temozolomide transport into prostate cancer cells.
    Pipkorn R; Waldeck W; Didinger B; Koch M; Mueller G; Wiessler M; Braun K
    J Pept Sci; 2009 Mar; 15(3):235-41. PubMed ID: 19177421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Diels-Alder-reaction with inverse-electron-demand, a very efficient versatile click-reaction concept for proper ligation of variable molecular partners.
    Wiessler M; Waldeck W; Kliem C; Pipkorn R; Braun K
    Int J Med Sci; 2009 Dec; 7(1):19-28. PubMed ID: 20046231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cyclic-RGD-BioShuttle functionalized with TMZ by DARinv "Click Chemistry" targeted to αvβ3 integrin for therapy.
    Braun K; Wiessler M; Pipkorn R; Ehemann V; Bäuerle T; Fleischhacker H; Müller G; Lorenz P; Waldeck W
    Int J Med Sci; 2010 Sep; 7(6):326-39. PubMed ID: 20922134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TMZ-BioShuttle--a reformulated temozolomide.
    Waldeck W; Wiessler M; Ehemann V; Pipkorn R; Spring H; Debus J; Didinger B; Mueller G; Langowski J; Braun K
    Int J Med Sci; 2008 Sep; 5(5):273-84. PubMed ID: 18797509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution flow cytometry: a suitable tool for monitoring aneuploid prostate cancer cells after TMZ and TMZ-BioShuttle treatment.
    Braun K; Ehemann V; Wiessler M; Pipkorn R; Didinger B; Mueller G; Waldeck W
    Int J Med Sci; 2009 Nov; 6(6):338-47. PubMed ID: 19946604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of glioblastoma multiforme cells with temozolomide-BioShuttle ligated by the inverse Diels-Alder ligation chemistry.
    Braun K; Wiessler M; Ehemann V; Pipkorn R; Spring H; Debus J; Didinger B; Koch M; Muller G; Waldeck W
    Drug Des Devel Ther; 2009 Feb; 2():289-301. PubMed ID: 19920915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theranostic cRGD-BioShuttle Constructs Containing Temozolomide- and Cy7 For NIR-Imaging and Therapy.
    Wiessler M; Hennrich U; Pipkorn R; Waldeck W; Cao L; Peter J; Ehemann V; Semmler W; Lammers T; Braun K
    Theranostics; 2011; 1():381-94. PubMed ID: 22211144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid lipid nanoparticles of temozolomide: potential reduction of cardial and nephric toxicity.
    Huang G; Zhang N; Bi X; Dou M
    Int J Pharm; 2008 May; 355(1-2):314-20. PubMed ID: 18255242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of temozolomide in hormone-refractory prostate cancer.
    van Brussel JP; Busstra MB; Lang MS; Catsburg T; Schröder FH; Mickisch GH
    Cancer Chemother Pharmacol; 2000; 45(6):509-12. PubMed ID: 10854140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971.
    van den Bent MJ; Taphoorn MJ; Brandes AA; Menten J; Stupp R; Frenay M; Chinot O; Kros JM; van der Rijt CC; Vecht ChJ; Allgeier A; Gorlia T;
    J Clin Oncol; 2003 Jul; 21(13):2525-8. PubMed ID: 12829671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O6-Methylguanine-DNA methyltransferase with O6-benzylguanine or O6-benzyl-2'-deoxyguanosine.
    Kokkinakis DM; Ahmed MM; Chendil D; Moschel RC; Pegg AE
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3801-7. PubMed ID: 14506174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ghee Butter as a Therapeutic Delivery System.
    Balasubramanian K; Evangelopoulos M; Brown BS; Parodi A; Celia C; Yazdi IK; Tasciotti E
    J Nanosci Nanotechnol; 2017 Feb; 17(2):977-82. PubMed ID: 29671486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
    Rainov NG; Fels C; Droege JW; Schäfer C; Kramm CM; Chou TC
    Cancer Gene Ther; 2001 Sep; 8(9):662-8. PubMed ID: 11593335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro responsiveness of glioma cell lines to multimodality treatment with radiotherapy, temozolomide, and epidermal growth factor receptor inhibition with cetuximab.
    Combs SE; Schulz-Ertner D; Roth W; Herold-Mende C; Debus J; Weber KJ
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):873-82. PubMed ID: 17544000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas.
    Kim JT; Kim JS; Ko KW; Kong DS; Kang CM; Kim MH; Son MJ; Song HS; Shin HJ; Lee DS; Eoh W; Nam DH
    Oncol Rep; 2006 Jul; 16(1):33-9. PubMed ID: 16786120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Orthogonal experiments for optimizing the formulation and preparation conditions of temozolomide solid lipid nanoparticles].
    Dou M; Huang G; Xi Y; Zhang N
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Oct; 25(5):1141-5. PubMed ID: 19024463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies.
    Britten CD; Rowinsky EK; Baker SD; Agarwala SS; Eckardt JR; Barrington R; Diab SG; Hammond LA; Johnson T; Villalona-Calero M; Fraass U; Statkevich P; Von Hoff DD; Eckhardt SG
    Clin Cancer Res; 1999 Jul; 5(7):1629-37. PubMed ID: 10430061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining adenoviral oncolysis with temozolomide improves cell killing of melanoma cells.
    Quirin C; Mainka A; Hesse A; Nettelbeck DM
    Int J Cancer; 2007 Dec; 121(12):2801-7. PubMed ID: 17724714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effect of temozolomide and hyperthermia on human melanoma cell growth and O6-methylguanine-DNA methyltransferase activity.
    Pagani E; Falcinelli S; Pepponi R; Turriziani M; Caporaso P; Caporali S; Bonmassar E; D'Atri S
    Int J Oncol; 2007 Feb; 30(2):443-51. PubMed ID: 17203227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.